Welcome to the homepage of AIHTA!
AIHTA is an acadmic non-profit institute. At our website we wish to present our research and give support for health care decision-making. Here all of our reports are available for free. For further information please contact the AIHTA team.
We are pleased to introduce our new reports.
Decision Support Documents 2015:
DSD 81: Fully bioresorbable scaffolds for coronary artery disease
DSD 82: Transcatheter mitral valve-in-valve implantation (TMViVI)
DSD 83: Endovascular embolization of unruptured intracranial aneurysms with flow diverters
DSD 84: Defibrotide for the treatment and prophylaxis of hepatic veno-occlusive disease
DSD 85: Intrastromal corneal implants for ectatic corneal disorders
DSD 86: Sphenopalatine Ganglion (SPG) stimulation of patients with therapy-resistant cluster headache
DSD 87: Injectable bulking agents for faecal incontinence
DSD 44/ 2nd Update 2015: Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation
DSD 68/ 1st Update 2015: Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB)
Project / Prevention and screening
Project team: Inanna Reinsperger
Duration: April 2015 - November 2015
Publication: LBI-HTA Projektbericht No. 83: https://eprints.aihta.at/1078/
Project / High tech medicine, Health economics
Robotic-assisted surgery: A systematic review of effectiveness and safety for elected indications and accumulating costs
Duration: May 2015 – November 2015
Publication: LBI-HTA Projektbericht No. 84: https://eprints.aihta.at/1077/
Sponsoring Austrian CME/ continuing medical education for physicians. A systematic analysis of the CME-Database
In recent years, the sponsorship of CME/ continuing medical education for physicians by the pharmaceutical and medical device industry is increasingly scrutinized. The question in this project was the scope of sponsoring in the Austrian CME-training. From the CME database of the Austrian Academy of doctors 13 medical fields (from a total of 56) were selected with the aim to analyse the number of events that were financially supported by manufacturer. The investigation shows that a sponsorship of at least 14.3% and at most 67.2% of the events took place. The sponsors are, as might be expected, pharmaceutical and medical product suppliers in the respective subject, mainly from "high-cost and / or high-volume" products.
Publication: Rapid Assessment 7a: https://eprints.aihta.at/1053
Contact: Claudia Wild
In 2008 the German AOK-Bundesverband commissioned the LBI-HTA to develop a decision-aid on the vaccination against Human Papillomavirus (HPV) for young women and girls (online since June 2009). After smaller updates in 2010 and 2011, the updated, completely revised and partly new structured decision-aid went online in March 2015 (www.hpv-entscheidungshilfe.de).The first part of the decision aid contains information about the virus and HPV related diseases. The second part of the decision aid informs about the HPV-vaccine(s). Finally, the third part of the decision aid summarises information of parts I and II: eleven short information blocks can be rated according to the relevance for the decision (mainly pro or mainly contra vaccination or of no influence). In the present project report online contents are available in paper form for the first time. Hence, we were able to add country specific data for Austria and provide further, more detailed information (which has not been included in the online version due to complexity).
Publication: Decision Support Document No. 79: https://eprints.aihta.at/1050
Contact: Brigitte Piso
We are pleased to introduce our new HSO report.